AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 11 min read$CXDO

Wang David Tzat-kin sold $162K of CXDO

Wang David Tzat-kin (Chief Technology Officer) sold 25,000 shares of Crexendo, Inc. (CXDO) at $6.50 ($0.16M total) on 2026-08-27.

Original reporting
SEC EDGAR · Wang David Tzat-kin
Published Sep 1, 2026, 10:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 10:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CXDO
Bearish
medium confidence
Mentioned
$CXDO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CXDOBearishLow
01

Why it matters

The CTO's sale adds modest selling pressure but does not materially alter CXDO's valuation.

02

Market read

A small insider sale; likely limited price effect.

03

What to watch

The insider still holds a large position, indicating continued confidence.

Relevance 4/10Novelty 4/10Timing: post-market Sep 1 filing

Background

Form 4 filings disclose insider transactions; they are primary sources for corporate insider activity.

Company-level read

Ticker impact

$CXDOBearishMedium confidence
Context

Chief Technology Officer sold 25,000 shares for $162,500 on 2026-08-27, reducing his stake to 534,747 shares.

Expected impact

Potential short-term dip of 1-2% as the market digests the sale.

Evidence & confidence

CTO insider sales often signal reduced confidence; however, the amount is small relative to total float.

Market effects

Sector

Minimal impact on the broader fintech sector.

Regional

Limited to US markets where CXDO trades.

Global

Low

Counterpoint

What could challenge this read

The sale could be routine liquidity management, not a negative signal.

Key entities

  • Company
    Crexendo, Inc.

    US-listed fintech firm (ticker CXDO).

  • Individual
    Wang David Tzat-kin

    Chief Technology Officer of Crexendo.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CXDO insider trading history →

Related articles

AUG 4
$CXDOMed

Crexendo Announces Strong Second Quarter 2026 Results

Crexendo, Inc. (CXDO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Crexendo Announces Strong Second Quarter 2026 Results PHOENIX, AZ / ACCESSWIRE / August 4, 2026 / Crexendo, Inc. (NASDAQ: CXDO), an award-winning software technology company that is a premier provider of cloud communication platform software and unified communication

SEC EDGAR 8-K6 min
MAY 30
$PAYMed

10 Best Growth Stocks to Buy with Low P/E Ratios

The article screens for growth stocks with average revenue growth of at least 30% over five years and forward P/E below 25, then ranks them by forward P/E. It highlights Paymentus (PAY) with forward P/E 22.92 and 31.72% revenue growth; Wedbush raised its target to $36 and Baird to $34 after strong Q1 results and raised 2026 guidance. It also cites Crexendo (CXDO) with forward P/E 18.73 and 32.99% growth; Needham raised its target to $12 after strong Q1 organic telecom growth and deal wins.

insidermonkey.com6 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min